FOLH1 and prostate cancer: Importantly, both 188Re- and 99mTc-labeled complexes of DP1-PSMAt and DP2-PSMAt show a high accumulation in PSMA-expressing tumors and prostate cancer cells and, in vivo, rapidly clear from the circulation via a renal pathway, with minimal retention in healthy tissues.